Actualités ARch Biopartners Inc (QB) - ACHFF | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

TORONTO, Canada -- November 5, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX...

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

TORONTO, Ontario, CANADA -- October 16, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the...

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

TORONTO, Canada -- June 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture:...

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

TORONTO, Canada -- May 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture:...

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

TORONTO, Canada -- April 24, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ARch Biopartners Inc (QB) (ACHFF)

Outils de qualité professionnelle, pour des investisseurs individuels.

ACHFF Actualités

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ARch Biopartners Inc (QB) (ACHFF) Actualités

ARch Biopartners Inc (QB) (ACHFF)

Outils de qualité professionnelle, pour des investisseurs individuels.

ACHFF Actualités

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application